Trial NCT01276704

View at ClinicalTrials.gov 
Org. Study IDs: 12377

Last trial update was posted on 2023-09-21

MeSH Interventions

Secoisolariciresinol

MeSH Conditions

Breast Neoplasms

Other Conditions

Breast Cancer

Stopping Reasons

accrual rate lower than anticipated; funding expired

Limitations And Caveats

Early termination led to small numbers of subjects analyzed. A total of 240 enrollees was planned; actual accrual was 180.

Result Publications


Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID